Rapt Therapeutics Inc banner

Rapt Therapeutics Inc
F:0RA

Watchlist Manager
Rapt Therapeutics Inc Logo
Rapt Therapeutics Inc
F:0RA
Watchlist
Price: 34 EUR -2.86% Market Closed
Market Cap: €1B

Intrinsic Value

0RA price has not been updated for more than 1 year. This may indicate that the stock has been delisted.

The intrinsic value for Rapt Therapeutics Inc (0RA) under the Base Case is 2.89 EUR. Compared with the current market price of 34 EUR, the stock appears Overvalued by 92% .

Based on two methods:

Both DCF and multiples point to overvaluation.

0RA Intrinsic Value
2.89 EUR
Overvaluation 92%
Intrinsic Value
Price €34
Base Case Scenario
Monitor 0RA
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value €2.31
Get notified when the price drops into your buy zone
Current Price €34
Intrinsic Value €2.89
Margin of Safety 20% €2.31
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about 0RA?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is 0RA valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Rapt Therapeutics Inc.

Explain Valuation
Alternatives to 0RA

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

RAPT Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 0RA stock?

The intrinsic value for Rapt Therapeutics Inc (0RA) under the Base Case is 2.89 EUR.

Is 0RA stock undervalued or overvalued?

Compared with the current market price of 34 EUR, the stock appears Overvalued by 92% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett